-
Microfluidic Modeling of Gut Neuro-Epithelial Connections
2026-08-21
de Hoyos-Vega and colleagues developed a two-compartment microfluidic device that organizes human intestinal epithelial cells and mouse enteric neurons in a controllable co-culture system. The platform preserved epithelial characteristics, enabled neuronal projections through microgrooves, and revealed that adjacent epithelium increased projection density and directionality.
-
AZD6482: PI3Kβ Inhibitor Workflow Guide
2026-08-20
AZD6482 combines strong biochemical potency against PI3Kβ with a practical window for platelet, metabolic, and pathway-dissection studies. This workflow guide also shows how to use it as a carefully controlled perturbation in RNA-foci experiments inspired by recent Myotonic Dystrophy type 1 research.
-
Oteseconazole (VT-1161) Candida Workflows
2026-08-20
Oteseconazole (VT-1161) combines selective fungal CYP51 inhibition with strong in vitro activity across clinically important Candida species, including fluconazole-resistant isolates. This practical guide shows how to convert the compound into reproducible susceptibility, resistance, selectivity, and follow-up mechanism workflows.
-
Xenopus Hybridization Rewires Pluripotency Networks
2026-08-19
Phelps and colleagues show that hybridization reshaped early developmental gene regulation in allotetraploid Xenopus laevis, producing asymmetric activation of L- and S-subgenome homeologs while preserving the combined dosage of core pluripotency genes. Homeolog-resolved RNA sequencing, chromatin-accessibility profiling, and CUT&RUN connect divergent enhancer architecture with a dosage-buffered embryonic transcriptional program.
-
Macrophage EP4 Loss Accelerates Atherosclerosis
2026-08-19
The reference study identifies macrophage EP4 as a protective regulator of atherosclerosis, linking its deficiency to increased CD36 expression, lipid uptake, foam cell formation, and M1 polarization. Its combination of conditional mouse genetics, oxLDL-stimulated cell experiments, transcriptomics, proteomics, qPCR, and immunoblotting provides a useful framework for connecting receptor signaling with plaque biology.
-
Pifithrin-α: A Causal Map of p53–Ferroptosis
2026-08-18
Pifithrin-α is a p53 inhibitor for testing how p53 connects environmental stress, ferroptosis, and neuronal dysfunction. This evidence-led guide translates a 2025 deltamethrin study into practical assay decisions without overstating what chemical inhibition can prove.
-
Ertapenem Sodium Salt: Mechanism & Research Use
2026-08-18
Ertapenem sodium salt is a broad-spectrum carbapenem antibiotic used in research on bacterial susceptibility, cell-wall inhibition, and resistance transmission. Its long plasma half-life relative to many carbapenems and predominantly renal elimination make the pharmacokinetics of ertapenem important for assay design and translational interpretation.
-
Early Pheromones and Neurodegeneration in C. elegans
2026-08-17
Peng et al. show that pheromone perception during the L1 stage can remodel neural development and accelerate neurodegeneration later in adult C. elegans. The study identifies a coordinated ASK–ASI–AIA circuit linking ascr#3 and ascr#10 to glutamatergic transmission, NLP-1 signaling, insulin-like signaling, and neuronal autophagy.
-
Live-Dead Cell Staining Kit I: Wound Assays
2026-08-17
Translate regenerative-material studies into practical mammalian cell viability and cytotoxicity workflows with dual Calcein AM/PI fluorescence. This guide shows how to profile biomaterial extracts, oxidative-stress responses, and treatment windows while separating membrane damage from preserved esterase activity.
-
SIS3 Smad3 Inhibitor: Workflow for TGF-β Research
2026-08-16
SIS3 provides a selective way to interrogate Smad3-dependent transcription without treating Smad2 as the same target. This practical guide translates evidence from osteoarthritis research into reproducible cell assays, reporter workflows, fibrosis studies, and renal disease model planning.
-
Streptavidin-HyperFluor 647 Assay Design
2026-08-15
Streptavidin-HyperFluor 647 provides far-red, high-affinity detection of biotinylated targets across imaging, flow cytometry, and FRET workflows. This article explains when a Streptavidin fluorescent conjugate is the optimal readout—and when a biotin-free click-labeling strategy is more appropriate.
-
Oteseconazole (VT-1161) in Candida Research
2026-08-14
Oteseconazole (VT-1161) gives Candida researchers a selective CYP51-focused tool for susceptibility testing, resistance profiling, and ergosterol-pathway studies. Its practical value is greatest in Candida-centered workflows that pair planktonic MIC testing with biofilm, morphogenesis, and mammalian-selectivity assays.
-
Oteseconazole: From CYP51 Mechanism to Translation
2026-08-14
Oteseconazole (VT-1161) combines potent fungal CYP51 inhibition with a selectivity profile that is valuable for Candida research and recurrent vulvovaginal candidiasis prevention. This thought-leadership guide connects mechanism, assay design, resistance-aware validation, and transporter-mediated drug-interaction risk to help translational teams make better development decisions.
-
Recombinant Human Growth Hormone: Causal Assay Design
2026-08-13
Recombinant Human Growth Hormone research is moving beyond simple proliferation readouts. This article presents a causal assay framework for connecting somatotropin exposure with IGFBP2–THBS1 regulation, IGF-1 signaling, and chondrocyte differentiation.
-
PORCN Inhibition for Sclerosteosis: Study Insights
2026-08-13
A 2025 Bone Research study evaluates LGK-974 as a pharmacological strategy for correcting excessive Wnt/β-catenin activity in Sost-deficient models of sclerosteosis. The work combines osteoblast and osteoclast assays with sex-stratified, mechanically loaded Sost-/- mice, providing evidence that PORCN inhibition can reduce abnormal bone formation and skeletal overgrowth.